Cancer drug delivery in the nano era: An overview and perspectives
Publication type: Journal Article
Publication date: 2017-02-01
scimago Q1
wos Q2
SJR: 0.915
CiteScore: 8.3
Impact factor: 3.9
ISSN: 1021335X, 17912431
PubMed ID:
28627697
Cancer Research
Oncology
General Medicine
Abstract
Nanomaterials are increasingly used as drug carriers for cancer therapy. Nanomaterials also appeal to researchers in the areas of cancer diagnosis and biomarker discovery. Several antitumor nanodrugs are currently being tested in preclinical and clinical trials and show promise in therapeutic and other settings. We review the development of nanomaterial drug carriers, including liposomes, polymer nanoparticles, dendritic polymers, and nanomicelles, for the diagnosis and treatment of various cancers. The prospects of nanomaterials as drug carriers for future clinical applications are also discussed.
Found
Nothing found, try to update filter.
Found
Nothing found, try to update filter.
Top-30
Journals
|
2
4
6
8
10
12
|
|
|
Journal of Drug Delivery Science and Technology
12 publications, 3.48%
|
|
|
Pharmaceutics
10 publications, 2.9%
|
|
|
International Journal of Molecular Sciences
9 publications, 2.61%
|
|
|
International Journal of Pharmaceutics
9 publications, 2.61%
|
|
|
Molecules
6 publications, 1.74%
|
|
|
International Journal of Biological Macromolecules
6 publications, 1.74%
|
|
|
Journal of Materials Chemistry B
6 publications, 1.74%
|
|
|
Nanomaterials
5 publications, 1.45%
|
|
|
Advanced Drug Delivery Reviews
5 publications, 1.45%
|
|
|
Nanomedicine
5 publications, 1.45%
|
|
|
Frontiers in Pharmacology
5 publications, 1.45%
|
|
|
Frontiers in Oncology
5 publications, 1.45%
|
|
|
ACS Biomaterials Science and Engineering
4 publications, 1.16%
|
|
|
Life Sciences
4 publications, 1.16%
|
|
|
ACS Applied Bio Materials
4 publications, 1.16%
|
|
|
Cancers
4 publications, 1.16%
|
|
|
Seminars in Cancer Biology
4 publications, 1.16%
|
|
|
Advanced Materials
3 publications, 0.87%
|
|
|
Frontiers in Bioengineering and Biotechnology
3 publications, 0.87%
|
|
|
Cancer Nanotechnology
3 publications, 0.87%
|
|
|
Journal of Pharmaceutical Sciences
3 publications, 0.87%
|
|
|
Biomedical Materials (Bristol)
3 publications, 0.87%
|
|
|
Materials Science and Engineering C
3 publications, 0.87%
|
|
|
ACS applied materials & interfaces
3 publications, 0.87%
|
|
|
Nanoscale
3 publications, 0.87%
|
|
|
Chemical Society Reviews
3 publications, 0.87%
|
|
|
Journal of Drug Targeting
3 publications, 0.87%
|
|
|
Drug Delivery
3 publications, 0.87%
|
|
|
Critical Reviews in Therapeutic Drug Carrier Systems
2 publications, 0.58%
|
|
|
2
4
6
8
10
12
|
Publishers
|
20
40
60
80
100
120
|
|
|
Elsevier
116 publications, 33.62%
|
|
|
MDPI
46 publications, 13.33%
|
|
|
Springer Nature
38 publications, 11.01%
|
|
|
American Chemical Society (ACS)
23 publications, 6.67%
|
|
|
Royal Society of Chemistry (RSC)
19 publications, 5.51%
|
|
|
Taylor & Francis
17 publications, 4.93%
|
|
|
Frontiers Media S.A.
17 publications, 4.93%
|
|
|
Wiley
13 publications, 3.77%
|
|
|
Bentham Science Publishers Ltd.
7 publications, 2.03%
|
|
|
IOP Publishing
6 publications, 1.74%
|
|
|
Hindawi Limited
5 publications, 1.45%
|
|
|
Walter de Gruyter
3 publications, 0.87%
|
|
|
Begell House
2 publications, 0.58%
|
|
|
American Scientific Publishers
2 publications, 0.58%
|
|
|
IntechOpen
2 publications, 0.58%
|
|
|
Research Square Platform LLC
2 publications, 0.58%
|
|
|
Mary Ann Liebert
1 publication, 0.29%
|
|
|
Spandidos Publications
1 publication, 0.29%
|
|
|
SAGE
1 publication, 0.29%
|
|
|
Federation of American Societies for Experimental Biology (FASEB)
1 publication, 0.29%
|
|
|
Ovid Technologies (Wolters Kluwer Health)
1 publication, 0.29%
|
|
|
Tomsk Cancer Research Institute
1 publication, 0.29%
|
|
|
OOO Zhurnal "Mendeleevskie Soobshcheniya"
1 publication, 0.29%
|
|
|
SPIE-Intl Soc Optical Eng
1 publication, 0.29%
|
|
|
Optica Publishing Group
1 publication, 0.29%
|
|
|
OAE Publishing Inc.
1 publication, 0.29%
|
|
|
Oxford University Press
1 publication, 0.29%
|
|
|
Tsinghua University Press
1 publication, 0.29%
|
|
|
Open Access House of Science and Technology (OAHOST)
1 publication, 0.29%
|
|
|
20
40
60
80
100
120
|
- We do not take into account publications without a DOI.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
345
Total citations:
345
Citations from 2025:
25
(7.25%)
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Li Q. et al. Cancer drug delivery in the nano era: An overview and perspectives // Oncology Reports. 2017. Vol. 38. No. 2. pp. 611-624.
GOST all authors (up to 50)
Copy
Li Q., Tan S., Li S., Shen Q., Wang K. Cancer drug delivery in the nano era: An overview and perspectives // Oncology Reports. 2017. Vol. 38. No. 2. pp. 611-624.
Cite this
RIS
Copy
TY - JOUR
DO - 10.3892/or.2017.5718
UR - https://doi.org/10.3892/or.2017.5718
TI - Cancer drug delivery in the nano era: An overview and perspectives
T2 - Oncology Reports
AU - Li, Qianqian
AU - Tan, Shirui
AU - Li, Shuan
AU - Shen, Qiang
AU - Wang, Kun-Hua
PY - 2017
DA - 2017/02/01
PB - Spandidos Publications
SP - 611-624
IS - 2
VL - 38
PMID - 28627697
SN - 1021-335X
SN - 1791-2431
ER -
Cite this
BibTex (up to 50 authors)
Copy
@article{2017_Li,
author = {Qianqian Li and Shirui Tan and Shuan Li and Qiang Shen and Kun-Hua Wang},
title = {Cancer drug delivery in the nano era: An overview and perspectives},
journal = {Oncology Reports},
year = {2017},
volume = {38},
publisher = {Spandidos Publications},
month = {feb},
url = {https://doi.org/10.3892/or.2017.5718},
number = {2},
pages = {611--624},
doi = {10.3892/or.2017.5718}
}
Cite this
MLA
Copy
Li, Qianqian, et al. “Cancer drug delivery in the nano era: An overview and perspectives.” Oncology Reports, vol. 38, no. 2, Feb. 2017, pp. 611-624. https://doi.org/10.3892/or.2017.5718.